Therefore, the preclinical intervention study using secondary abiotic IL-10−/− mice as a C. jejuni infection model provides a new promising approach for prophylaxis and treatment of acute campylobacteriosis by vitamin C administration. Here, IL10 is linked to campylobacteriosis.